Adverse drug reactions due to drug–drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method

Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions

(2015) R. W. F. van Leeuwen et al.   ANNALS OF ONCOLOGY

Variability of Voriconazole Plasma Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Cytochrome P450 Polymorphisms and Comedications on Initial and Subsequent Trough Levels

(2015) Elodie Gautier-Veyret et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Critical appraisal of AMSTAR: challenges, limitations, and potential solutions from the perspective of an assessor

(2015) Clovis Mariano Faggion   BMC Medical Research Methodology

Appropriate Prescribing and Important Drug Interactions in Older Adults

(2015) Jeffrey Wallace et al.   MEDICAL CLINICS OF NORTH AMERICA

Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

(2014) Tommy Andersson et al.   American Journal of Cardiovascular Drugs

Retrospective evaluation of methotrexate elimination when co-administered with proton pump inhibitors

(2014) David J. Reeves et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation of the Effect of Multiple Doses of Lansoprazole on the Pharmacokinetics and Safety of Ponatinib in Healthy Subjects

(2014) Narayana I. Narasimhan et al.   CLINICAL DRUG INVESTIGATION

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update

(2014) Ralph-Steven Wedemeyer et al.   DRUG SAFETY

Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy

(2014) Miho Yamasaki et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The Proton Pump Inhibitor Lansoprazole, but not Rabeprazole, the Increased Blood Concentrations of Calcineurin Inhibitors in Japanese Patients with Connective Tissue Diseases

(2014) Kentaro Isoda et al.   INTERNAL MEDICINE

The clopidogrel conundrum

(2014) Joseph S. Bertino   JOURNAL OF CLINICAL PHARMACOLOGY

Clopidogrel, CYP2C19 and proton pump inhibitors: What we know and what it means

(2014) Sudharshan Hariharan et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective

(2014) Roelof W F van Leeuwen et al.   LANCET ONCOLOGY

In Vitro and In Situ Evaluation of pH-Dependence of Atazanavir Intestinal Permeability and Interactions with Acid-Reducing Agents

(2014) Olena Kis et al.   PHARMACEUTICAL RESEARCH

Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients

(2013) Daniel E Freedberg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE

Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors

(2013) Antoinette R. Tan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Potential Interactions with Anticancer Agents: A Cross-Sectional Study

(2013) A. Mouzon et al.   CHEMOTHERAPY

Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients

(2013) Waleed Alhazzani et al.   CRITICAL CARE MEDICINE

The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects

(2013) Yi Ding et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

The influence of comedication on tacrolimus blood concentration in patients subjected to kidney transplantation: a retrospective study

(2013) Neven Vavic et al.   EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

Antiplatelet drug interactions with proton pump inhibitors

(2013) Stuart A Scott et al.   Expert Opinion on Drug Metabolism & Toxicology

Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board

(2013) Anna Amrit Jarchow-MacDonald et al.   Geriatrics & Gerontology International

Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development

(2013) Gillian S. Smelick et al.   MOLECULAR PHARMACEUTICS

Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients

(2013) John P. Knorr et al.   TRANSPLANTATION

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors

(2013) Jai Moo Shin et al.   Journal of Neurogastroenterology and Motility

Evaluation of Potential Interactions between Mycophenolic Acid Derivatives and Proton Pump Inhibitors

(2012) Steven Gabardi et al.   ANNALS OF PHARMACOTHERAPY

Therapeutic Drug Monitoring of Posaconazole in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

(2012) M. Vaes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors

(2012) Chun Shing Kwok et al.   Expert Opinion On Drug Safety

No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: Meta-analysis

(2012) Chun Shing Kwok et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Quality appraisal in systematic reviews of public health interventions: an empirical study on the impact of choice of tool on meta-analysis

(2012) Peer H Voss et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Patients with advanced lung cancer: is there scope to discontinue inappropriate medication?

(2012) Adam Todd et al.   International Journal of Clinical Pharmacy

Report of the 2010-2011 Standing Committee on Advocacy: Leveraging Faculty Engagement to Improve Public Policy

(2011) Renee E. Coffman et al.   AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION

Influence of H2-receptor antagonists and proton pump inhibitors on dasatinib pharmacokinetics in Japanese leukemia patients

(2011) Naoto Takahashi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A Meta-Analysis of Impact of Proton Pump Inhibitors on Antiplatelet Effect of Clopidogrel

(2011) Mao Chen et al.   Cardiovascular Therapeutics

In vivo Enhancement in Bioavailability of Atazanavir in the Presence of Proton-Pump Inhibitors using Mesoporous Materials

(2011) Xin Xia et al.   ChemMedChem

Hepatic Drug Interaction Between Tacrolimus and Lansoprazole in a Bone Marrow Transplant Patient Receiving Voriconazole and Harboring CYP2C19 and CYP3A5 Heterozygous Mutations

(2011) Takuya Iwamoto et al.   CLINICAL THERAPEUTICS

Interactions Between Clopidogrel and Proton Pump Inhibitors: A Review of Evidence

(2011) C. Munoz-Esparza et al.   CURRENT MEDICINAL CHEMISTRY

Prescribing proton pump inhibitor and clopidogrel together

(2011) Neena S. Abraham   CURRENT OPINION IN GASTROENTEROLOGY

Lack of Significant Interactions Between Clopidogrel and Proton Pump Inhibitor Therapy: Meta-Analysis of Existing Literature

(2011) Lauren B. Gerson et al.   DIGESTIVE DISEASES AND SCIENCES

Effects of Proton Pump Inhibitors on Platelet Function in Patients Receiving Clopidogrel

(2011) Chun Shing Kwok et al.   DRUG SAFETY

Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers

(2011) M. G. Kees et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Anti-platelet therapy and managing ulcer risk

(2011) Francis K L Chan   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients

(2011) Sieglinde Kofler et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

(2011) T. Burkard et al.   JOURNAL OF INTERNAL MEDICINE

A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient

(2011) Michelle Maguire et al.   PEDIATRIC TRANSPLANTATION

Clinical Implications of the Nelfinavir–Proton Pump Inhibitor Drug Interaction in Patients with Human Immunodeficiency Virus

(2011) Parya Saberi et al.   PHARMACOTHERAPY

From QUOROM to PRISMA: A Survey of High-Impact Medical Journals' Instructions to Authors and a Review of Systematic Reviews in Anesthesia Literature

(2011) Kun-ming Tao et al.   PLoS One

Aspergilosis cardíaca en una paciente trasplantada de corazón

(2011) Alia Eworo et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy

(2011) Himawan Fernando et al.   THROMBOSIS AND HAEMOSTASIS

Pharmacists’ attitudes towards an evidence-based approach for over-the-counter medication

(2011) Lezley-Anne Hanna et al.   International Journal of Clinical Pharmacy

The potential interaction between clopidogrel and proton pump inhibitors: a systematic review

(2010) Joao Paulo de Aquino Lima et al.   BMC Medicine

Drug-Drug Interaction Profiles of Proton Pump Inhibitors

(2010) Ryuichi Ogawa et al.   CLINICAL PHARMACOKINETICS

Effects of Proton Pump Inhibitors on Adverse Gastrointestinal Events in Patients Receiving Clopidogrel

(2010) Chun Shing Kwok et al.   DRUG SAFETY

Review Article: Combination of Clopidogrel and Proton Pump Inhibitors: Implications for Clinicians

(2010) Marie Tran et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

The Effect of Acid Reduction With a Proton Pump Inhibitor on the Pharmacokinetics of Lopinavir or Ritonavir in HIV-Infected Patients on Lopinavir/Ritonavir-Based Therapy

(2010) Edgar T. Overton et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects

(2010) Li Zhu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Controversy of proton pump inhibitor and clopidogrel interaction: A review

(2010) HJ TAN   Journal of Digestive Diseases

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis

(2010) J. M. SILLER-MATULA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Drug Interaction Between Clopidogrel and Proton Pump Inhibitors

(2010) Tina J Liu et al.   PHARMACOTHERAPY

Proton Pump Inhibitor Co-medication Reduces Active Drug Exposure in Heart Transplant Recipients Receiving Mycophenolate Mofetil

(2010) A.O. Doesch et al.   TRANSPLANTATION PROCEEDINGS

Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors

(2009) E. J. Last et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Drug–Drug Interaction Between Clopidogrel and the Proton Pump Inhibitors

(2009) Nicholas B Norgard et al.   ANNALS OF PHARMACOTHERAPY

Current Standings of the Proton Pump Inhibitor and Clopidogrel Co-Therapy: Review on an Evolving Field with the Eyes of the Gastroenterologist

(2009) Márk Juhász et al.   DIGESTION

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

(2009) Beverley J. Shea et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers

(2009) Korbinian Rupprecht et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Real world reviews: a beginner's guide to undertaking systematic reviews of public health policy interventions

(2009) C. Bambra   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease

(2009) Toru Hiyama et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Can We Systematically Review Studies That Evaluate Complex Interventions?

(2009) Sasha Shepperd et al.   PLOS MEDICINE

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

(2008) G. Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy

(2008) Kunihiro Suzuki et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Significant Decrease in Nelfinavir Systemic Exposure After Omeprazole Coadministration in Healthy Subjects

(2007) Annie F Fang et al.   PHARMACOTHERAPY